
Education
Drexel University Thomas R. Kline School of Law
Juris Doctor, 2000
Philadelphia College of Pharmacy/University of the Sciences (Now St. Joseph’s University)
Doctor of Pharmacy (PharmD): 2015
B.S. in Pharmaceutical and
Healthcare Studies: 2013
Bar Admissions
• Commonwealth of Pennsylvania
and the USPTO
Bryce G. Kleeman is an associate who primarily assists in the preparation, filing, and prosecution of biotechnology and life science patents, both U.S. and foreign. Bryce received his J.D. from Drexel University Thomas R. Kline School of Law where he was the vice-president of the Intellectual Property Law Society and a recipient of the Robert B. Washburn Intellectual Property Law Scholarship. He is also a Pennsylvania registered pharmacist having received both his PharmD and B.S. in Pharmaceutical and Healthcare Studies from the Philadelphia College of Pharmacy/University of Sciences (Now St. Joseph’s University) where he was the president of the Rho Chi Pharmacy Honor Society. Bryce is admitted to practice law in Pennsylvania and before the United States Patent and Trademark Office.
Before joining Howson & Howson, Bryce was patent counsel and corporate counsel at a gene therapy pharmaceutical company where he helped protect the company’s intellectual property, namely through the preparation and prosecution of patents directed to large molecule gene therapies as well as through partnering and due diligence efforts. He also provided litigation support for a European Patent Opposition and the associated Oral Proceedings. His 5+ year journey at this gene therapy company started with his being a legal intern while attending law school.
Prior to his career in intellectual property law, Bryce practiced as an inpatient hospital pharmacist and additionally helped teach a pharmacy laboratory course as an adjunct faculty member which prepared pharmacy students for real world medication counseling as well as sterile IV preparation and compounding in a hospital setting. His time as a pharmacist has given Bryce a unique vantage point into the lifecycle of various pharmaceutical products, from discovery to dispensing.
